This topic contains a solution. Click here to go to the answer

Author Question: Reducing recidivism is the primary goal of a specific deterrence model. Indicate whether the ... (Read 34 times)

folubunmi

  • Hero Member
  • *****
  • Posts: 524
Reducing recidivism is the primary goal of a specific deterrence model.
 
  Indicate whether the statement is true or false

Question 2

People suffering from conduct disorder have difficulty following rules and behaving in a socially acceptable way.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

KKcool

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

TRUE

Answer to Question 2

TRUE




folubunmi

  • Member
  • Posts: 524
Reply 2 on: Aug 13, 2018
YES! Correct, THANKS for helping me on my review


Zebsrer

  • Member
  • Posts: 284
Reply 3 on: Yesterday
Excellent

 

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library